Influence of Prior Walking on Postprandial Metabolism in Centrally Obese Men
1 other identifier
interventional
30
1 country
1
Brief Summary
The present study will investigate the effect of prior walking on postprandial metabolism and endothelial function in centrally obese South Asian and White European men. Participants will complete two, 2-day trials in a random, crossover design separated by at least a week. On day 1, participants will either rest or complete a 60 minute walk at 60% maximal oxygen uptake. On day 2, participants will arrive at 08:00 having fasted overnight and a baseline venous blood sample and endothelial function measurement will be taken. Participants will consume a high-fat breakfast and lunch and 12 subsequent venous blood samples will be taken throughout the day at standardised intervals to measure a variety of coronary heart disease risk markers. A second endothelial function measurement will be completed 2 hours after the breakfast. Blood pressure will be measured every hour. It is expected that the South Asian participants will have impaired metabolism and endothelial function compared to their European counterparts but the bout of exercise performed on day 1 will mitigate these responses.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable diabetes-mellitus-type-2
Started Jan 2019
Shorter than P25 for not_applicable diabetes-mellitus-type-2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 3, 2019
CompletedFirst Submitted
Initial submission to the registry
May 13, 2019
CompletedFirst Posted
Study publicly available on registry
May 16, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2019
CompletedJanuary 29, 2020
January 1, 2020
8 months
May 13, 2019
January 27, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
Triacylglycerol changes in response to exercise and feeding
Fasting on day 1 and 2. Time-course of plasma triacylglycerol concentrations in response to exercise and/or feeding on day 2.
Day 1 fasting. Day 2 fasting (0 hour point), 1.5hours, 1.75hours, 2hours, 3hours, 4hours, 5hours, 5.5hours, 5.75hours, 6hours, 7hours, 8hours and 9hours.
Endothelial function changes in response to exercise and feeding
Changes in endothelial function via flow-mediated dilatation in response to feeding and exercise.
Day 1 fasting and 8.75hours. Day 2 fasting and 2.5hours.
Secondary Outcomes (12)
Glucose changes in response to exercise and/or feeding
Day 1 fasting. Day 2 fasting (0 hour point), 1.5hours, 1.75hours, 2hours, 3hours, 4hours, 5hours, 5.5hours, 5.75hours, 6hours, 7hours, 8hours and 9hours.
Blood pressure changes in response to exercise and/or feeding
Day 1 fasting. Day 2 fasting (0 hour point) and 1hours, 2hours, 3hours, 4hours, 5hours, 6hours, 7hours, 8hours and 9hours.
Total cholesterol
Day 1 fasting. Day 2 fasting.
Insulin changes in response to exercise and/or feeding
Day 1 fasting. Day 2 fasting (0 hour point), 1.5hours, 2hours, 4hours, 5hours, 5.5hours, 7hours, 8hours.
High-density lipoprotein cholesterol
Day 1 fasting. Day 2 fasting.
- +7 more secondary outcomes
Study Arms (2)
Experimental: Exercise
EXPERIMENTALExercise: Participants will walk for 60 minutes at 60% maximal oxygen uptake on day 1.
No Intervention: Control
NO INTERVENTIONParticipants will rest on day 1.
Interventions
Eligibility Criteria
You may qualify if:
- to 60 year old South Asian and White European men;
- Centrally obese (waist circumference \>90cm for South Asians, \>94cm for White Europeans);
- Weight stable for the past 3 months;
- Non-smokers;
- No known contradictions to maximal exertion exercise.
You may not qualify if:
- Musculoskeletal injury that has affected normal ambulation within the last month;
- Congenital heart disease;
- Any muscle or bone injuries that do not allow them to walk on a treadmill;
- Uncontrolled exercise-induced asthma;
- Coagulation or bleeding disorders;
- Diabetes (metabolism will be different to non-diabetics potentially skewing the data);
- Taking any medication that might influence fat metabolism;
- Taking any medication that might influence blood glucose (e.g., insulin for diabetes);
- Heart conditions;
- Smoking;
- Dieting or restrained eating behaviours;
- Weight fluctuation greater than 3 kg in the previous 3 months to study enrolment;
- A food allergy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Loughborough Universitylead
- University Hospitals, Leicestercollaborator
Study Sites (1)
National Centre for Sport and Exercise Medicine, Loughborough University
Loughborough, LE11 3TU, United Kingdom
Related Publications (2)
Arjunan SP, Deighton K, Bishop NC, King J, Reischak-Oliveira A, Rogan A, Sedgwick M, Thackray AE, Webb D, Stensel DJ. The effect of prior walking on coronary heart disease risk markers in South Asian and European men. Eur J Appl Physiol. 2015 Dec;115(12):2641-51. doi: 10.1007/s00421-015-3269-7. Epub 2015 Oct 5.
PMID: 26438068BACKGROUNDArjunan SP, Bishop NC, Reischak-Oliveira A, Stensel DJ. Exercise and coronary heart disease risk markers in South Asian and European men. Med Sci Sports Exerc. 2013 Jul;45(7):1261-8. doi: 10.1249/MSS.0b013e3182853ecf.
PMID: 23470315BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David Stensel
Loughborough University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
May 13, 2019
First Posted
May 16, 2019
Study Start
January 3, 2019
Primary Completion
September 1, 2019
Study Completion
September 1, 2019
Last Updated
January 29, 2020
Record last verified: 2020-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- The data will become available in 6 months after publication for 1 year.
- Access Criteria
- Data will be available to other researchers who would like to run the same statistical methods we have used to check the interpretation of results.
Anonymised individual participant data for all primary and secondary outcome measures will be made available upon request. Study protocol, statistical analysis plan and informed consent forms are also available upon request.